Flow-Mediated Dilatation and Asymmetric Dimethylarginine Do Not Predict Mortality in Peritoneal Dialysis Patients

Flow-Mediated Dilatation and Asymmetric Dimethylarginine Do Not Predict Mortality in Peritoneal Dialysis Patients

Aim: Asymmetric dimethylarginine (ADMA) is associated with increased coronary artery disease risk through endothelial dysfunction in dialysis patients. We aimed to investigate the role of flow-mediated dilatation (FMD), a non-invasive indicator of endothelial function, and ADMA in mortality in perit...

Full description

Bibliographic Details
Main Authors: Sami Uzun, Serhat Karadağ, Meltem Gürsu, Egemen Cebeci, Ahmet Gürdal, Tuba Elif Şenel, Ayça Eroğlu, Savaş Öztürk
Format: Article
Language:English
Published: Galenos Yayinevi 2017-09-01
Series:Haseki Tıp Bülteni
Subjects:
Flow mediated dilatation
asymmetric dimethylarginine
endothelial dysfunction
peritoneal dialysis
mortality
Online Access:http://www.hasekidergisi.com/article_15427/Flow-mediated-Dilatation-And-Asymmetric-Dimethylarginine-Do-Not-Predict-Mortality-In-Peritoneal-Dialysis-Patients

Internet

http://www.hasekidergisi.com/article_15427/Flow-mediated-Dilatation-And-Asymmetric-Dimethylarginine-Do-Not-Predict-Mortality-In-Peritoneal-Dialysis-Patients

Similar Items